Wound healing is a dynamic and highly coordinated process involving inflammatory responses, extracellular matrix remodeling, cellular signaling, oxidative stress, and microbial activity. Healthy skin maintains an acidic surface pH, typically around 4 to 6, which supports barrier function and limits the growth of harmful microbes. When skin is injured, the wound environment shifts, and in chronic wounds—such as diabetic foot ulcers, venous leg ulcers, and pressure sores—the pH is frequently dysregulated, often drifting toward alkaline values. A recent prospective multicenter cohort study cited in the review found progressive acidification of wounds as they healed and persistently higher pH in chronic non-healing wounds, underscoring pH as a clinically meaningful biomarker rather than a passive chemical detail.

The consequences of altered wound pH ripple through nearly every stage of repair. Elevated pH promotes bacterial colonization and biofilm formation, the slimy microbial communities that shield pathogens from antibiotics and immune cells. It also modulates the activity of matrix metalloproteinases, enzymes that degrade the extracellular matrix; in chronic wounds, an imbalance between these enzymes and their natural inhibitors, the tissue inhibitors of metalloproteinases, leads to excessive destruction of newly formed tissue. Altered pH further influences reactive oxygen species generation, inflammatory signaling pathways, the migration of keratinocytes and fibroblasts, angiogenesis, and the assembly of collagen and other matrix components. In short, the review argues, pH is not merely a symptom of a troubled wound—it is an active driver of healing failure.

At the molecular level, pH responsiveness in polymers arises from protonation and deprotonation reactions. Weak acid groups, such as the carboxyl groups in polyacrylic acid and alginate, shed protons and become negatively charged as pH rises, while weak base groups, such as the amine groups in chitosan, poly(N,N-dimethylaminoethyl methacrylate), and polyhistidine, gain protons and become positively charged as pH falls. The review is careful to distinguish these ionization processes from their downstream physicochemical consequences: changes in charge density alter electrostatic repulsion within the polymer network, driving swelling or collapse; changes in ionization state alter solubility, permeability, and degradation kinetics; and all of these together govern when and how fast a loaded drug is released. Sulfonamide-containing polymers, for example, undergo sharp solubility transitions near physiological pH, a property that has been exploited for on-demand delivery.

Translating this chemistry into clinical tools, researchers have built pH-responsive systems across an impressive range of formats. Hydrogels—water-swollen polymer networks—are the workhorse platform, with formulations based on natural polymers such as chitosan, alginate, hyaluronic acid, and gelatin, often cross-linked through dynamic Schiff base bonds that form and break depending on acidity. Nanoparticles, nanofibers, microspheres, injectable systems, microneedle arrays, and multifunctional wound dressings round out the arsenal. In one cited example, a pH-responsive calcium alginate hydrogel laden with protamine nanoparticles and hyaluronan oligosaccharides promoted diabetic wound healing by enhancing both angiogenesis and antibacterial activity. In another, a chitosan and protocatechualdehyde hydrogel formed via Schiff base chemistry delivered antioxidant and antibacterial effects precisely where the wound environment triggered it.

Some of the most striking recent work combines pH responsiveness with other therapeutic modalities. The review highlights dual- and multi-responsive hydrogels that react simultaneously to pH, reactive oxygen species, glucose, temperature, or near-infrared light. A near-infrared and pH dual-responsive chitosan hydrogel containing epigallocatechin gallate and hollow copper sulfide nanoparticles was reported to reprogram ROS dynamics for infected wound healing, while a triple-responsive supramolecular hydrogel with a synergistic photothermal effect regulated inflammatory signaling to remodel the diabetic wound microenvironment. These systems embody the concept of microenvironment-feedback regulation: the material senses pathological conditions and releases its therapeutic payload only when and where it is needed, reducing off-target exposure and drug waste.

The review also surveys an emerging convergence between responsive biomaterials and diagnostics. Optical and electrochemical biosensing, wearable monitoring devices, and intelligent therapeutic approaches are being integrated directly into dressings. Carbon quantum dot-entrapped hydrogels with sensitive pH response and photodynamic antibacterial properties have been developed for visual, intelligent wound monitoring, allowing clinicians to read wound status by color change. Dual-responsive surface-enhanced Raman scattering nanoprobes have been used for real-time imaging of pH and ROS dynamics during healing. Electrochemical immunosensing platforms can now measure matrix metalloproteinases MMP-2 and MMP-9 directly from chronic wound exudates without labels, and hyaluronic acid hydrogel-based biosensors paired with artificial intelligence are being explored for continuous monitoring of chronic wound healing. Wireless, closed-loop smart bandages with integrated sensors and stimulators, described in Nature Biotechnology, point toward a future in which the dressing both diagnoses and treats.

The clinical stakes are enormous. Chronic wounds affect millions of patients worldwide and impose a substantial burden on health systems, particularly among people with diabetes, vascular disease, and immobility. Conventional dressings are largely passive, delivering drugs at fixed rates regardless of the wound’s state. pH-responsive platforms promise something fundamentally different: dressings that act as closed-loop therapeutic agents, releasing antimicrobials when bacterial alkalization signals infection, scavenging excess reactive oxygen species when oxidative stress spikes, and modulating protease activity when matrix destruction runs out of control. Because the trigger is the wound’s own chemistry, the same material can behave differently in a healing wound versus a stalled one, matching therapy to need.

The authors are candid about the obstacles standing between laboratory promise and clinical reality. Response specificity remains a challenge, since pH changes in wounds are gradual and can overlap with other chemical shifts, making it difficult to design materials that respond only within the desired window. Stability in the harsh, enzyme-rich, and microbe-laden wound fluid is another concern, as is biosafety, particularly for cationic polymers and nanoparticle components whose long-term toxicity profiles require careful evaluation. Scalability of manufacturing—especially for microfluidically synthesized particles and precisely engineered multilayer systems—and the cost and regulatory hurdles of clinical translation add further friction. The review also notes that wound pH depends on factors such as wound size and measurement technique, complicating the standardization needed for regulatory approval.

What emerges from the analysis is a call for rational, mechanism-driven design rather than trial-and-error formulation. By integrating wound microenvironmental biology—cellular crosstalk, inflammatory pathways, redox balance, protease dynamics, and biofilm behavior—with the molecular physics of ionizable polymers, the authors propose a framework for developing next-generation pH-responsive platforms for precision wound management and tissue regeneration. If that framework succeeds, the humble bandage could evolve from a passive covering into an active, sensing, self-regulating therapeutic system—one that reads the chemistry of the wound beneath it and responds in real time, bringing a genuinely intelligent layer to one of medicine’s oldest challenges.

Subject of Research: pH-responsive biomaterials for wound healing and their molecular mechanisms

Article Title: pH-responsive biomaterials for wound healing: molecular mechanisms, therapeutic applications, and future perspectives

Article References: Rattan, D., Kumar, D., Awasthi, A., Singh, T. G., & Kumar, M. (2026). pH-responsive biomaterials for wound healing: molecular mechanisms, therapeutic applications, and future perspectives. Journal of Materials Science. https://doi.org/10.1007/s10853-026-13780-y

Image Credits: AI Generated

DOI: 10.1007/s10853-026-13780-y

Keywords: pH-responsive biomaterials, wound healing, chronic wounds, hydrogels, drug delivery, chitosan, alginate, hyaluronic acid, biofilms, reactive oxygen species, smart dressings, biosensors

The biology of a stalled wound is strikingly different from that of a healthy one. Normal healing proceeds through four coordinated stages: hemostasis, inflammation, proliferation, and remodeling, orchestrated by a cast of cells and growth factors. Chronic wounds, particularly diabetic foot ulcers, are trapped in a hostile microenvironment defined by elevated reactive oxygen species (ROS), persistent bacterial biofilms, hypoxia, and an overabundance of matrix metalloproteinases that chew through the extracellular matrix. In diabetes, hyperglycemia drives the formation of advanced glycation end-products, which fuel chronic inflammation and further oxidative stress. Infections by Staphylococcus aureus and Pseudomonas aeruginosa deepen the problem, colonizing tissue, prolonging inflammation, and impairing the clotting and angiogenesis processes the wound needs to recover.

Conventional care has not kept pace with this complexity. Debridement, the surgical or enzymatic removal of dead tissue, remains the gold standard for cleaning the wound bed, but it is painful, requires skilled surgeons, and does nothing to correct the underlying biochemistry. Autologous skin grafts still deliver the best cosmetic and functional outcomes, yet donor sites are limited, and even engineered skin substitutes fall short of a complete replacement. Topical growth factors and antimicrobials help, but wound exudates rapidly degrade free drugs. The review’s central argument is that advanced materials must do more than cover a wound: they must actively modulate the microenvironment, scavenging excess ROS, delivering growth factors intact, and dismantling biofilms.

Natural polymers form the backbone of many next-generation dressings precisely because they speak the body’s language. Collagen, roughly 30 percent of animal protein, provides a triple-helical scaffold that supports cell attachment, induces coagulation, and releases bioactive peptides with immunomodulatory, antibacterial, and antioxidative activity. Silk fibroin from the Bombyx mori silkworm offers antimicrobial properties, moisture retention, gas exchange, and negligible immunogenicity. Keratin, long overlooked as a therapy, has recently attracted attention: keratin 17 surges at wound margins after injury, and mice lacking it heal poorly, while keratin-derived dressings accelerated epithelialization in pig models. Alginate from brown seaweed absorbs exudates and keeps the wound moist, and hyaluronic acid, a glycosaminoglycan of the extracellular matrix, actively promotes angiogenesis, though it must be blended with other macromolecules for mechanical strength.

Synthetic and hybrid systems address the weaknesses of natural polymers, which suffer from batch-to-batch variability and poor mechanical consistency. Polyurethane films, hydrogels, foams, and hydrocolloids can be engineered with reproducible properties, and the review highlights work showing polyurethane dressings producing thinner scabs and earlier vascularized granulation tissue than a commercial control. The authors argue that hybrid composite scaffolds combining natural bioactivity with synthetic reliability represent the optimal strategy for clinical translation, a theme that recurs throughout their functional classification of biomaterial platforms.

The most technically rich section of the review concerns nanoparticles themselves. Silver nanomaterials, already commercialized in dressings such as Acticoat, kill bacteria by deactivating enzymes, modifying thiol groups on cysteine residues, and generating ROS; proteomic studies show they disable outer-membrane proteins in E. coli and block proton transfer, starving cells of ATP. Zinc oxide nanoparticles exploit size-dependent effects, entering bacterial cells through nanometer-scale surface pores and producing hydrogen peroxide and ROS that also stimulate fibroblast growth. Gold nanoparticles, particularly when paired with light stimulation or antioxidants like epigallocatechin gallate, enhanced keratinocyte and fibroblast proliferation and angiogenic signaling in animal studies. Copper nanoparticles, notably two-and-a-half to six times less toxic than copper salts, address the trace-metal deficits that slow healing.

Emerging materials aim directly at the diabetic wound’s oxidative chaos. Cerium oxide nanoparticles mimic the enzymes superoxide dismutase and catalase, neutralizing ROS while activating the PI3K/Akt and Wnt/beta-catenin pathways that drive endothelial cell proliferation and new blood vessel formation. When conjugated with microRNA-146a or embedded in gelatin methacryloyl hydrogels, they reduce inflammation and accelerate closure without antibiotics. Silica nanoparticles release silicic acid that promotes fibroblast migration, and mesoporous versions serve as high-capacity drug carriers. Self-assembling peptide nanostructures offer cytocompatible, non-immunogenic scaffolds that can be tailored with cell-adhesion epitopes. Carbon-based materials round out the arsenal: fullerenes scavenge reactive oxygen and nitrogen species, graphene oxide encourages keratinocyte migration and angiogenesis, and carbon nanotubes composited with chitosan enhanced collagen deposition in vivo.

Delivery architecture matters as much as the therapeutic cargo. Polymeric nanoparticles made of PLGA protect drugs from wound proteases and release them in a sustained fashion; LL37-loaded PLGA particles promoted cell migration and granulation in full-thickness wound models. Liposomes and niosomes carry both hydrophilic and lipophilic agents, and a silk-fibroin-cored liposome preserved basic fibroblast growth factor in wound secretions while accelerating angiogenesis. Solid lipid nanoparticles and nanostructured lipid carriers achieved high encapsulation efficiency and superior stability, delivering recombinant human EGF to diabetic mice with marked improvements in re-epithelialization. Electrospun nanofibers mimic the extracellular matrix’s topography, coaxial variants sustaining drug release for up to 30 days, while nanohydrogels absorb exudate, admit oxygen, and can be loaded with stimuli-sensitive cargo.

The next generation of dressings is designed to think. pH-responsive nanofibers signal and treat infection, since chronic and infected wounds trend alkaline. Thermoresponsive meshes with biodegradable metallic heaters release drugs on demand, enzyme-responsive systems degrade in the presence of overexpressed matrix metalloproteinases or bacterial lipases, and ROS-cleavable hydrogels unload anti-inflammatory payloads exactly where oxidative stress reigns. The review frames this as a shift from passive, one-size-fits-all coverage toward personalized, dynamic therapy, though it cautions that manufacturing complexity and sensor stability in the harsh wound bed remain significant hurdles.

The translational roadmap is candid about where each technology stands. Drug-loaded dressings built on FDA-approved polymers with established metals like silver and zinc oxide, plus lipid nanoparticles, are closest to the clinic because regulatory pathways already exist. Cerium oxide platforms and smart stimuli-responsive hydrogels, despite immense promise for diabetic wounds, still need extensive long-term toxicity and biodistribution data, since silver accumulation illustrates the risks of established materials. The authors call for rigorous nanotoxicology monitoring, scalable manufacturing including 3D and 4D bioprinting of nanocomposite scaffolds, and point-of-care diagnostics that analyze wound exudate to prescribe multifunctional dressings matched to each patient’s microenvironment. If those pieces come together, the stubborn ulcers that medicine has managed for decades may finally be engineered to heal.

Subject of Research: Nano-architected biomaterials and smart drug delivery systems for chronic and diabetic wound healing

Article Title: Nano-architectures in wound healing: Smart delivery systems, mechanistic insights, and translational roadmap

Article References: Nano-architectures in wound healing: Smart delivery systems, mechanistic insights, and translational roadmap. (n.d.). https://doi.org/10.1016/j.rechem.2026.103803

Image Credits: AI Generated

DOI: 10.1016/j.rechem.2026.103803

Keywords: nanotechnology, wound healing, diabetic foot ulcers, nanoparticles, cerium oxide, silver nanoparticles, hydrogels, drug delivery, electrospun nanofibers, ROS scavenging, biomaterials, smart dressings

The central argument of the review is that modern wound care needs materials that do more than cover. Biomaterial-based polymeric patches are designed to combine three functions in a single platform: structural support for fragile new tissue, controlled delivery of therapeutic agents, and direct regenerative activity. Achieving that combination requires careful attention to a set of design determinants that the authors lay out systematically. Biocompatibility ensures the material does not provoke an immune attack; biodegradability allows the patch to be absorbed as the wound heals rather than requiring painful removal; mechanical integrity keeps the patch intact under the stresses of movement; and the polymer’s origin, whether natural or synthetic, shapes degradation rates, cell interactions, and regulatory pathways. Increasingly, researchers are also incorporating bioactive secondary metabolites, plant-derived compounds and other natural molecules with documented anti-inflammatory, antimicrobial, and pro-regenerative effects, to give the patch genuine pharmacological punch.

Among the most versatile platforms are hydrogels, three-dimensional polymer networks that can hold large quantities of water while remaining soft and tissue-like. Hydrogels maintain the moist environment that wound healing requires, and their crosslinked structure can be tuned to release drugs over hours or days. The review highlights natural polymer hydrogels based on alginate, chitosan, and carboxymethyl cellulose, which have shown anti-inflammatory and healing-accelerating effects in both in vitro and in vivo studies. Photo-crosslinkable gelatin methacryloyl hydrogels allow researchers to pattern the material with light, creating scaffolds that mimic the extracellular matrix. Injectable hydrogel formulations are pushing further, offering targeted control of oxidative stress, one of the key biochemical culprits that keeps diabetic wounds locked in a chronic, non-healing state. Conductive hydrogel patches add yet another dimension, using bioelectric stimulation to encourage cell migration and regeneration while doubling as wearable sensors.

Electrospun nanofiber scaffolds represent a second major architectural family. By drawing polymer solutions through an electric field, manufacturers can produce mats of fibers with diameters in the nanometer range, closely resembling the fibrous architecture of the natural extracellular matrix. This biomimetic topology encourages cells to attach, proliferate, and migrate across the wound bed. The review cites work on polycaprolactone-zinc scaffolds coated with fibroblast-derived extracellular matrix, which enhanced cell proliferation, migration, and fibroblast differentiation, and on radially oriented berberine-loaded PHBV nanofiber dressings designed to accelerate diabetic wound closure. Electrospun dressings loaded with carbon quantum dots and citrate have demonstrated improved antibacterial efficiency, and the technology has begun to appear in real-world clinical evaluation, with commercial systems such as Spincare being assessed for practical wound coverage.

Microneedle arrays are perhaps the most visually striking of the new architectures. These patches studded with microscopic needles, often tens to hundreds of micrometers tall, can painlessly penetrate the tough, dead surface layer of a chronic wound and deposit drugs, growth factors, or biomolecules directly into viable tissue below. The review describes bioinspired wearable polymer microneedle patches developed specifically for diabetic wound therapy, as well as multifunctional designs such as a kangfuxin-chitosan-fucoidan complex patch that enabled full-thickness wound healing in preclinical models, and ROS-scavenging microneedle patches that mop up the reactive oxygen species implicated in chronic inflammation. Because microneedles can be engineered from dissolving or biodegradable polymers, they can leave no sharps waste and release their payload as they dissolve, combining delivery, mechanical debridement of the wound surface, and safety in one device.

Multilayered composite dressings take a different approach to the same problem: rather than one material doing everything, they assign each layer a job. A typical bilayer or trilayer patch might feature a tough, bacteria-blocking outer film, a middle layer that stores and slowly releases therapeutics, and a soft, adhesive inner layer that conforms to the wound. The review points to examples including gelatin-chitosan bilayer patches loaded with medicinal plant extracts, tri-layer dressings combining zinc oxide nanoparticles with insulin-like growth factor 1 for full-thickness skin injuries, and pollen-integrated hydrogel patches with hierarchical structures that release active compounds in a spatio-temporally controlled fashion. This architectural sophistication mirrors the layered structure of skin itself and allows formulators to reconcile requirements, such as moisture retention and mechanical strength, that would otherwise conflict within a single material.

The most futuristic entries in the review are the smart, responsive patches that merge wound care with diagnostics. Hydrogel-based electronic-skin patches have been demonstrated that both accelerate healing and monitor the state of the wound in real time. Conducting polymer arrays with multiplex sensing and drug-delivery capabilities form the basis of next-generation smart bandages, while a negative-pressure smart patch has been reported that can both sense wound conditions and apply therapy on demand. Wearable platforms built on hydrogels are being designed to track biomarkers such as pH, temperature, uric acid, and moisture, parameters that correlate with infection and healing progress, and to trigger therapeutic release only when needed. The authors note that artificial intelligence is beginning to enter this space, with machine-learning approaches proposed for interpreting sensor data and personalizing treatment, turning the humble dressing into a closed-loop therapeutic system.

Underpinning all of these architectures is a growing appreciation of wound biology. The review situates material design within the cellular choreography of repair: the inflammatory phase dominated by macrophages whose plasticity determines whether healing proceeds or stalls, the proliferative phase in which fibroblasts lay down new matrix and new blood vessels form, and the remodeling phase that determines final scar quality. In diabetic and chronic wounds, elevated oxidative stress, persistent infection, and dysregulated inflammation derail this sequence. Bioactive metabolites from plants, marine peptides, and even microbial sources are being explored as natural modulators that can nudge the wound environment back toward regeneration, and polymer chemists are learning to embed these molecules without destroying their activity.

Yet the review’s most sobering contribution is its assessment of translation. Despite an impressive laboratory literature, the number of advanced polymeric patches that have reached routine clinical use remains small. The authors identify a cluster of recurring barriers: manufacturing scalability, since processes like electrospinning and microneedle molding are difficult to reproduce at industrial scale with consistent quality; product standardization, because natural polymers vary batch to batch; regulatory approval pathways that were not designed for combination products blending drug, device, and biological functions; cost-effectiveness in health systems already strained by chronic wound care; and, above all, the scarcity of large-scale clinical validation. Registered clinical trials of advanced patches, including nitric oxide-releasing patches for diabetic foot ulcers and hemostatic patches for surgery, exist but remain limited in number and scope relative to the volume of preclinical publications. The review also flags the poor quality of many animal studies and calls for better standardized reporting, citing newly proposed guidelines for wound-healing research.

The overall picture that emerges is of a field at an inflection point. The material science has arguably outpaced the clinical science: researchers can now build patches that sense, deliver, stimulate, and regenerate, but the pathway from elegant prototype to approved, affordable, widely available product remains bottlenecked by economics, regulation, and evidence. By integrating advances in material design with an honest appraisal of translational and clinical considerations, Nandi and colleagues offer a framework intended to help the next generation of patches cross that gap. For the millions of patients whose wounds will not heal, the promise is real, but so, the review makes clear, is the distance still to travel.

Subject of Research: Bioactive polymeric patches and advanced dressing architectures for chronic wound healing and their translational challenges

Article Title: Next-generation bioactive polymeric patches for chronic wound healing: from advanced architectures to translational challenges

Article References: Nandi, A., Ahmed, R. K., & Chakrabarti, S. (2026). Next-generation bioactive polymeric patches for chronic wound healing: from advanced architectures to translational challenges. Polymer Bulletin, 83(12), Article 643. https://doi.org/10.1007/s00289-026-06697-8

Image Credits: AI Generated

DOI: 10.1007/s00289-026-06697-8

Keywords: chronic wounds, wound healing, biomaterials, hydrogels, electrospun nanofibers, microneedles, smart dressings, drug delivery, tissue regeneration, polymers, diabetic ulcers, clinical translation